BACKGROUND: Single embryo transfer (SET) pregnancies practically lack vanishing twins and may be associated with improved neonatal outcome. Our objective was to compare the obstetric and neonatal outcome of SET singletons with the outcome of singletons following double embryo transfer (DET) and spontaneous conception. METHODS: A 7-year (1997METHODS: A 7-year ( -2003 cohort of fresh SET (n 5 269) and DET (n 5 230, including 25 vanishing twins) cycles resulting in singleton birth at Helsinki University Central Hospital, Finland, was linked to the Finnish Medical Birth Register and the obstetric and neonatal outcome data compared with that from 15 037 spontaneously conceived singleton pregnancies. RESULTS: The obstetric and neonatal outcome of the SET group was comparable to that in the DET group. Compared with the comparison cohort, gestational hypertension (P 5 0.005), placenta praevia (P < 0.001), preterm contractions (P 5 0.01) and maternal hospitalization (P < 0.001) was more typical of women in the SET group. After adjusting for age, parity and socio-economic status the SET pregnancies showed increased risks of Caesarean section [odds ratio (OR) 1.54 with 95% confidence interval (CI) 1.18-2.00], preterm birth (OR 2.85; 95% CI 1.96-4.16) and low birthweight (OR 2.01; 95% CI 1.19-3.99) compared with the comparison cohort. CONCLUSIONS: Our results indicate that subject-and infertility-related mechanisms other than the number of transferred embryos influence the neonatal outcome of singleton IVF pregnancies.
Introduction
IVF is associated with increased risks of maternal and neonatal complications in singleton pregnancies (Helmerhorst et al., 2004; Jackson et al., 2004; Källén et al., 2005a,b) . Frequently reported maternal complications in IVF singleton pregnancies are pre-eclampsia, vaginal bleeding, placenta praevia and placental abruption (Jackson et al., 2004; Källén et al., 2005a) . With respect to the neonatal outcome, the risks of preterm birth, low birthweight (LBW), neonatal intensive care unit (NICU) admission and perinatal mortality are significantly higher in singleton IVF pregnancies than in spontaneously conceived, age-and parity-matched pregnancies (Helmerhorst et al., 2004; Källén et al., 2005b) . Furthermore, a higher rate of congenital anomalies in IVF singletons than in non-IVF singletons has been reported (Wennerholm et al., 2000; Anthony et al., 2002; Hansen et al., 2002 Hansen et al., , 2005 Klemetti et al., 2005; Källén et al., 2005c) .
Although infertility per se independently increases the risks of prematurity and neonatal mortality, the role of IVF treatment in increased maternal and neonatal risks remains unclear (Draper et al., 1999; Basso and Baird, 2003) . One possible mechanism behind the higher rates of neonatal complications in singleton IVF pregnancies is related to the number of transferred embryos. In 10% of singleton pregnancies following double embryo transfer (DET), the development of one embryo ends and only one child is later born (Pinborg et al., 2005) . These vanishing twin survivors have an elevated risk of preterm birth and LBW compared with singletons originating from a single gestation (Dickey et al., 2002; Schieve et al., 2004; Pinborg et al., 2005) . Possibly, the poorer neonatal outcome of the vanishing twin survivor cohort has contributed to the overall results of neonatal outcome of IVF singletons. To date, the majority of published data on neonatal outcome of IVF singletons is based on singleton pregnancies following DET.
In the past 9 years, a marked shift from DET to single embryo transfer (SET) has taken place in Finland (Vilska et al., 1999; Tiitinen and Gissler, 2004) . Currently, nearly 50% of all embryo transfers in Finland are performed as SET and 87.7% of infants born after IVF are singletons (National Research and Development Centre for Welfare and Health (STAKES), Statistical summary 2006a). The outcome of SET pregnancies is not biased by the worse outcome of the vanishing twin subgroup.
The objective of this study was to analyse the obstetric and neonatal outcome of singleton pregnancies achieved by means of either SET or DET. In addition, the obstetric and neonatal outcome of the SET singletons was compared with that of spontaneously conceived singletons.
Materials and methods
During the study period 1997 -2003, 2353 fresh embryo transfers following either IVF or ICSI were carried out at the Infertility Clinic of Helsinki University Central Hospital (HUCH), Finland. Five hundred and four (21.4%) of these transfers proceeded to a viable singleton pregnancy and were the couple's first IVF/ICSI pregnancies. After excluding cases involving preimplantation genetic diagnosis (n ¼ 2) and one live birth abroad, a total of 501 singleton IVF/ICSI pregnancies were linked to the Finnish Medical Birth Register (MBR), Hospital Discharge Register (HDR) and the Register of Congenital Malformations (RCM) according to the woman's and child's unique identification number. Two of these 501 pregnancies ended in elective termination of pregnancy in the second trimester (indications: spina bifida and trisomy 21) and the remaining 499 pregnancies, 269 SET and 230 DET, formed the final study group.
The study group's pregnancies were achieved after the 'long' ovarian stimulation protocol and standard IVF/ICSI culture, as described previously (Tiitinen et al., 2001) . Forty-five of of 269 singleton pregnancies in the SET group followed compulsory SET (16.7%) whereas 224 followed elective SET (eSET; 83.3%). Elective transfer of one embryo was performed most commonly (in 95%) when at least one four-cell embryo with less than 20% fragmentation and without multinucleated blastomeres existed 2 days after oocyte retrieval and at least one embryo could be frozen. During the first three study years , DET was the primary option and eSET was performed in order to avoid maternal obstetric risks and also because of a couple's wish to avoid multiple pregnancy (Vilska et al., 1999) . Thereafter, eSET was the first treatment option for all IVF patients in our clinic. DET took place in cases where there was no medical contraindication for twin pregnancy and the subject had had two previous unsuccessful IVF cycles, or poor quality embryos (Tiitinen et al., 2003) . Transvaginal ultrasonography (TVS) was first performed before the end of the eighth gestational week and secondly before the 14th gestational week.
The comparison cohort group registered as spontaneously conceived (n ¼ 15 037) was randomly taken from the MBR. The comparison cohort represented a 10% population-based random sample of all singleton pregnancies and births matched for the year of delivery and mother's place of residence.
All maternal, obstetric and neonatal variables were collected retrospectively from the above-mentioned nationwide health registers held by STAKES. The MBR provides information on maternal characteristics and obstetric and neonatal variables (up to the infant's age of 7 days) associated with all live-born or stillborn infants born after the 22nd gestational week or weighing 500 g or more. The MBR data are submitted by delivery hospitals and complemented by data on live births from the Population Register Centre and data on deaths (during the first week of life) from the Cause-of-Death Register at Statistics Finland. Coverage of the MBR is practically 100% and the data quality is good (Gissler et al., 1995) . The maternal variables included in this study were age, socio-economic status (SES) based on maternal occupation, area of residence, number and type of previous pregnancies (categorized as miscarriages, induced abortions and ectopic pregnancies) and deliveries, smoking (yes or no), number of outpatient visits, prevalence of maternal hospitalization during the pregnancy and onset and type of delivery. The neonatal variables included were gestational age at birth (defined according to the best clinical estimation), birthweight, small for gestational age [SGA according to national sex-specific standards (Pihkala et al., 1989) ], low 1 min Apgar scores (0-6), NICU admission and perinatal death (stillbirths and neonatal deaths during the first week of life).
The HDR includes information on outpatient and inpatient care in all hospitals according to diagnosis based on the 10th revised version of the International Classification of Diseases (ICD 10) (Keskimäki and Aro, 1991) and surgical procedures based on the national version of the Nordic Classification of Surgical Procedures. For this study, relevant obstetric diagnoses (ICD 10 codes O10 to O99) and surgical procedures (MA2AA to MWW96) related to the studied pregnancy and 42 days after it were collected.
The RCM contains data on congenital anomalies diagnosed during the child's first year of life from hospitals, health-care professionals, cytogenetic laboratories and health registers of STAKES and Statistics Finland. The coverage and validity of RCM data is good after multisource data collection. A congenital anomaly is defined as a structural anomaly, a chromosomal defect or congenital hypothyroidism in live-born and stillborn infants and fetuses aborted before the 24th gestational week. The congenital anomalies are registered and included to RCM according to instructions of European Surveillance for Congenital anomalies.
This study was approved by the Administrative Head of Department of Obstetrics and Gynaecology, HUCH. Permission to use register data as well as data linkages between different registers was given by STAKES.
Statistical analyses
First, (unadjusted) differences in maternal characteristics and obstetric and neonatal outcome were compared between the SET and the DET group and between the SET and the comparison cohort using Student's t-test, univariate analysis of variance, the x 2 -test and Fisher's exact test. Next, comparisons with the comparison cohort adjusted for maternal age, parity and SES were run by using logistic regression. Because smoking and SES are strongly correlated (Jaakkola et al., 2001) only SES was included in the logistic regression model. The results were displayed as odds ratios (ORs) with 95% confidence intervals (CIs). Risks of selected maternal complications and Caesarean section (CS) were studied in the SET group. The risks of preterm birth, LBW, SGA, low 1 min Apgar scores and NICU admission in the SET and DET groups were then calculated. The unadjusted neonatal outcome (including mean gestational age at birth, and birthweight, low Apgar scores, NICU admissions and perinatal death) was compared between the vanishing twin survivors and the SET group in a subanalysis. The statistical analyses were performed by using the eighth version of SAS (SAS Institute, Cary, NC, USA). A P-value of ,0.05 was regarded as being statistically significant.
Results
The SET mothers were younger than the DET mothers but older than the mothers in comparison cohort (Table I) . Except for more frequent smoking in the SET group than in the DET group the background characteristics were similar in these groups. Compared with the comparison cohort, the SET mothers were of higher SES, smoked less frequently during pregnancy and had fewer previous pregnancies (except for ectopic pregnancies) and live births than the comparison cohort mothers.
The aetiology of infertility in the IVF group was tubal in 91 (18.2%), other female in 149 (29.9%), male in 104 (20.8%), combined in 32 (6.4%) and unexplained in 123 (24.6%).
IVF was carried out in 367 (73.5%) and ICSI in 132 (26.5%) of the cycles. The frequencies of the different aetiologies and treatments did not vary between the SET and the DET group. In the DET group, 25 (10.9%) vanishing twin pregnancies were diagnosed in the early TVS. Cessation of development of one embryo took place before the eighth gestational week in 12 (48%) of the vanishing twin pregnancies and the rest were diagnosed by the 14th gestational week.
The occurrence of pregnancy complications was similar in the SET and DET groups with the exception of more frequent placental abruption after DET (Table II) . Gestational hypertension, deep venous thrombosis, gestational diabetes, maternal care because of congenital malformation of the uterus and cervical incompetence, placenta praevia and preterm contractions were more frequent in the SET group than in the comparison cohort (Table II) . After adjusting for age, parity and SES, increased risks of gestational hypertension (OR 2.35; 95% CI 1.57-3.53), deep venous thrombosis (OR 27.7; 1.49-513.8), maternal care because of congenital malformation of the uterus (OR 5.55; 1.14-27.0) and cervical incompetence (OR 7.85; 2.81-21.9), placenta praevia (OR 4.75; ) and preterm contractions (OR 2.70; 1.83-3.98) were found. In addition, cerclage suture for cervical incompetence was more typical in the SET group (n ¼ 3, 1.1%) than in the comparison cohort (n ¼ 11, 0.07%) (P ¼ 0.005). The SET mothers visited maternity clinic less frequently than the DET mothers but more frequently than the mothers in the comparison cohort. Maternal hospitalization during pregnancy (total) and immediately before and after delivery was similar in the SET and DET groups, but more typical of the SET group than the comparison cohort.
Induction of delivery was equally common to all groups (Table III) . The SET and DET groups did not differ in the Pregnancy outcome after single embryo transfer frequency of vacuum extractions or CS but vacuum extractions and emergency CS were more frequent in the SET group than in the comparison cohort. The age-, parity-and SES-adjusted risks of CS (OR 1.54; 1.18 -2.00), postpartum curettage (OR 8.03; 2.52-25.6) and of manual removal of the placenta (OR 2.50; 1.50-4.16) were also elevated in the SET group. The mean gestational age at birth and the mean birthweight were comparable in the SET and DET groups but lower in the SET group than in the comparison cohort (Table IV) . The rates of preterm birth, LBW, SGA infants, low 1 min Apgar scores and NICU admission did not differ between the SET and DET groups. As regards preterm birth, LBW and low 1 min Apgar scores, the SET group had statistically higher rates than the comparison cohort. Perinatal mortality rates (total) did not differ between the groups, but the rate of stillbirths was higher in the SET group than in the comparison cohort.
Age-, parity-and SES-adjusted logistic regression analysis revealed no significant differences in neonatal outcome between the SET and DET groups (Table V) . In comparison with the comparison cohort, increased risks of preterm birth (OR 2.85; 1.96-4.16), LBW (OR 2.01; 1.19-3.99) and low Apgar scores (OR 1.96; 1.01 -2.82) were found for SET pregnancies (Table V) . When comparing the DET group with the comparison cohort, increased risks of preterm birth (OR 2.63; 1.73 -4.00), LBW (OR 3.46; 2.20 -5.46), low Apgar scores (OR 1.75; 1.01 -3.04) and NICU admission (OR 2.23; 1.08-4.58) were observed.
In the whole IVF group, 26 cases (519/10 000) with major congenital malformation in elective terminations of pregnancy and stillborn and live-born children were observed. These 26 cases included eight cases with major cardiovascular defects, four cases with major urogenital anomalies, one case with spina bifida, one with choanal atresia, three cases with syndromes and nine other. No difference in the prevalence of major congenital anomalies between the SET (555/10 000) and DET group (476/10 000) existed (P ¼ 0.84).
In a subanalysis, the neonatal outcome of the vanishing twin survivors was compared with that in the SET group. No significant differences between the vanishing twin survivors and the infants in the SET group were found as regards mean gestational age at birth (38.2 + 3.1 weeks versus 38.6 + 2.5, P ¼ 0.27), mean birthweight (3120 + 718 g versus 3328 + 627 g, P ¼ 0.08), rates of SGA infants (8.0% versus 4.5%, P ¼ 0.22), low 1 min Apgar scores (16.0% versus 6.7%, P ¼ 0.10) and perinatal mortality (4% versus 1.3%, P ¼ 0.16).
Discussion
The major achievement of active SET policy is the significant decline in the multiple pregnancy rate after IVF and the associated overall improvement in maternal and neonatal morbidity (Gerris and Van Royen 2000; Thurin et al., 2004; Tiitinen and Gissler 2004) . We hypothesized that the SET practice could also be related to improved neonatal outcome in singleton IVF pregnancies because SET pregnancies lack vanishing twin survivors. However, according to our results, from a large Finnish University Hospital Clinic, the obstetric and neonatal outcomes were very similar in the SET and DET groups. Moreover, more frequent obstetric complications and increased neonatal risks in the SET group were found compared with the comparison cohort.
Our results have to be weighed against the strengths and limitations of our study. We consider the consistent, accurate and population-based data collected by STAKES as a strength. The limitations of this study, on the other hand, are the retrospective setting, the unequal distribution of women with suspected or known obstetric risks in the SET and DET groups and the relatively small sample size. In our clinic, SET was primarily implemented in women with suspected obstetric risks (such as a chronic disease, uterine anomaly, previous hysterotomy or cervical incompetence) and secondarily in women with a good prognosis. In addition, our SET sample might represent a selected group, because the most complicated cases of infertility were referred to and treated in our tertiary clinic. With our sample size, only a two-fold difference between the SET and the comparison cohort and a two-and-a-half-fold difference between the SET and the DET groups could have been detected with 80% power and a significance of 0.05. Therefore, any conclusions based on an observed difference less than the magnitude given earlier should be interpreted cautiously. But because active SET policy has been driven only for couple of years and up-to-date knowledge of outcome after SET is scarce, the information provided from a material with even limited sample size may be of importance.
The inclusion of subjects with known/suspected obstetric risk factors in our SET group distinguishes this study from previous SET studies concerning subjects with good prognosis (De Sutter et al., 2003; De Neubourg et al., 2006; Thurin Kjellberg et al., 2006) . However, IVF practice involves subjects with suboptimal prognosis and the obstetric and neonatal results associated with good prognosis subjects cannot be generalized to others. Therefore, results from a heterogeneous subject group, such as the present SET group, are needed. Ideally, however, the impact of number of transferred embryos on obstetric and neonatal outcome of IVF singletons should be studied in a well-conducted observational study with sufficient samples and after adjusting for various known obstetric and neonatal risk factors.
Previously, only more frequent hypertensive disorders of pregnancy in SET versus spontaneous pregnancies have been reported (De Neubourg et al., 2006) . In our SET sample, along with the age-and parity-adjusted risk of gestational hypertension (but not pre-eclampsia), the risks of deep venous thrombosis, placenta praevia, preterm contractions and maternal care because of cervical incompetence and congenital malformation of the uterus were higher in the SET group than in the comparison cohort. Our results are not surprising when keeping in mind the fact that an increased risk of placenta praevia has also been reported in larger samples of IVF singleton pregnancies (Jackson et al., 2004; Källen et al., 2005a; Romunstad et al., 2006) . Furthermore, the inclusion of women with known malformation of the uterus and a history of cervical incompetence in our SET group probably explains the increased risks of maternal care for these indications during pregnancy. In line with the results of larger cohort studies on IVF singletons, but in contrast to the study by De Neubourg and colleagues, an increased risk of CS in the SET group was proposed (Klemetti et al., 2002; Källén et al., 2005a; De Neubourg et al., 2006) .
The mean gestational age at birth and the mean birthweight of the SET singletons in our sample were comparable with data from two earlier observational studies, despite differences in characteristics between our SET group and the SET groups in these studies (De Sutter et al., 2003; De Neubourg et al., 2006) . However, these measures were lower in our SET group than in a randomized Scandinavian study carried out by Thurin-Kjellberg et al. (2006) . Also in accordance with the results of previous work (De Neubourg et al., 2006; Thurin-Kjellberg et al., 2006) but contradictory to the work from De Sutter and colleagues (De Sutter et al., 2006) , the number of preterm births remained close to 10% even if only one embryo was transferred. Interestingly, preterm birth rates ranging from 9% to 14% have also been reported in several IVF cohort studies, with the great majority of singleton births following the transfer of numerous embryos (Klemetti et al., 2002; Schieve et al., 2004; Källén et al., 2005b) . Given that preterm birth is the most important factor that affects other neonatal outcome parameters, we suggest that SET does not necessarily decrease the rate of all neonatal complications in singleton IVF pregnancies. Other risk factors related to infertility and/or its causes, or the IVF treatment itself, may be explanatory as regards increased prematurity (Kapiteijn et al., 2006) . As a logical consequence of increased preterm rates in our sample, the adjusted risks of LBW and low Apgar scores were also increased in the SET group compared with the comparison cohort. In contrast, the insignificant risk of SGA infants suggests that the lower gestational age rather than growth retardation accounts for the lower birthweight in the SET infants. However, with our sample size we have a limited power to draw definite conclusions from any risk with OR less than two. We could not adjust the comparison of perinatal deaths because of the limited number of cases in this material. The prevalence of congenital anomalies was higher in our SET and DET groups than in the general Finnish population (on average 295/ 10 000), but similar to that in a larger Finnish study on congenital anomalies after IVF in live-born and stillborn infants (STAKES 2006b; Klemetti et al., 2005) . In total, the obstetric and neonatal results in our SET group were to a great extent like the results from other IVF singleton cohorts (Klemetti et al., 2002 (Klemetti et al., , 2005 Schieve et al., 2004; Källén et al., 2005a, b, c) .
Unlike previous studies on altogether 1191 vanishing twin assisted reproduction technique pregnancies (Dickey et al., 2002; Pinborg et al., 2005) , we did not find a statistically significant association between adverse neonatal outcomes and vanishing twin survivors -possibly resulting from our relative small subgroup of vanishing twin survivor. In nearly half of the vanishing twin pregnancies, the co-twin had died early (i.e. before the eighth gestational week) as compared to 36% and 66% reported from Dickey et al. (2002) and Pinborg et al. (2005) , respectively.
Conclusion
Our results suggest that even the most optimal IVF treatment, eSET, does not completely moderate the adverse neonatal outcomes for singletons associated with underlying infertility. Nevertheless, eSET definitely lowers the overall risks of adverse neonatal outcome by decreasing the number of multiple pregnancies and is a better option than DET for a woman with obstetric risk factors. In an IVF practice, the real challenge is to maintain acceptable pregnancy rates and to optimize the possibility of a safe pregnancy, even in subjects with a poor prognosis. In our opinion, this challenge is best met with eSET.
